345226-22-4

Basic information

• Product Name: 1-Bromo-2-chloro-4-difluoromethoxybenzene
• Synonyms: 1-Bromo-2-chloro-4-difluoromethoxybenzene;2-BROMO-5-(DIFLUOROMETHOXY)CHLOROBENZENE(WXFC0732)
• CAS NO: 345226-22-4
• Molecular Formula: C₇H₄BrClF₂O
• Molecular Weight: 257.47
• Mol File: 345226-22-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Bromo-2-chloro-4-difluoromethoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-2-chloro-4-difluoromethoxybenzene(345226-22-4)
• EPA Substance Registry System: 1-Bromo-2-chloro-4-difluoromethoxybenzene(345226-22-4)

Safety Data

• Hazardous Substances Data: 345226-22-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-2-chloro-4-difluoromethoxybenzene is used as an intermediate in the production of pharmaceuticals for its ability to be incorporated into the molecular structures of various drugs, enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Bromo-2-chloro-4-difluoromethoxybenzene is utilized as a precursor in the synthesis of agrochemicals, contributing to the development of more effective and targeted pest control agents.
Used in Organic Synthesis:
1-Bromo-2-chloro-4-difluoromethoxybenzene serves as a key building block in organic synthesis processes, allowing for the creation of a wide range of chemical compounds with diverse applications across different industries.

Upstream product

• 13631-21-5 4-bromo-3-chlorophenol 
• 87189-16-0 potassium 2-bromo-2,2-difluoroacetate 

Relevant articles and documents

PYRIDINE AND PYRIMIDINE CARBOXYLATE HERBICIDES AND METHODS OF USE THEREOF

Provided herein are pyridine and pyrimidine carboxylates and their derivatives, and compositions and methods of use thereof as herbicides.

ANTIDIABETIC BICYCLIC COMPOUNDS

Tricyclic compounds containing a cyclopropyl carboxylic acid or carboxylic acid derivative (e.g. amide) fused to a bicyclic ring, including pharmaceutically acceptable salts and prodrugs thereof, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.